Status:

COMPLETED

D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months

Lead Sponsor:

McMaster University

Collaborating Sponsors:

Canadian Institutes of Health Research (CIHR)

Conditions:

Deep Vein Thrombosis

Pulmonary Embolism

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

The purpose of this study is to determine if the risk of recurrent venous thromboembolism (VTE) after stopping therapy is low and acceptable in patients with a first unprovoked proximal deep vein thro...

Eligibility Criteria

Inclusion

  • Be \>= 18 years of age
  • Have had ONE episode of unprovoked proximal DVT and/or PE
  • Have completed 3 uninterrupted months of warfarin therapy (target INR of 2.0-3.0)

Exclusion

  • Another indication for long-term anticoagulation (e.g., atrial fibrillation)
  • A high risk of bleeding as evidenced by any of the following:
  • Age greater than 75 years
  • Previous episode of major bleeding where the cause was not effectively treated
  • Known chronic thrombocytopenia with a platelet count of less than 120,000 x 10\^9 /L
  • Known chronic renal impairment with a creatinine of more than 150 mumols /litre (1.7 mg/dl)
  • Known chronic liver disease with a total bilirubin of more than 25 mumols /litre (1.5 mg/dl)
  • Active peptic ulcer disease
  • Poor compliance with, or control of, anticoagulant therapy during initial treatment
  • Requires dual antiplatelet therapy (e.g. aspirin and clopidogrel)
  • A vena caval filter
  • Has had D-dimer testing performed within 2 months of potential enrollment other than for evaluation of suspected recurrent VTE that was not confirmed
  • Has a life expectancy less than 5 years
  • Is unable to attend follow-up visits because of geographic inaccessibility
  • Is participating in a competing clinical investigation

Key Trial Info

Start Date :

September 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2016

Estimated Enrollment :

410 Patients enrolled

Trial Details

Trial ID

NCT00720915

Start Date

September 1 2008

End Date

December 1 2016

Last Update

December 13 2016

Active Locations (13)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (13 locations)

1

Lombardi Cancer Center

Washington D.C., District of Columbia, United States, 20057

2

University of Iowa Hospitals and Clinics

Iowa City, Iowa, United States, 52242

3

Brigham and Women's Hospital

Boston, Massachusetts, United States, 02115

4

Beth Israel Deaconess Medical Centre

Boston, Massachusetts, United States, 02215